左旋硝基精氨酸诱导的高血压大鼠心肌和血管的肾上腺髓质素与受体活性修饰蛋白2表达的变化

探讨高血压大鼠心肌和血管的肾上腺髓质素（adrenomedullin,ADM）与受体活性修饰蛋白2（receptoractivity-modifying protein 2,RAMP2）mRNA的变化。用一氧化氮合酶（NOS）竞争性抑制剂左旋硝基精氨酸（L-NNA）阻断NOS制备大鼠高血压模型。用放射免疫分析方法测定血浆、心肌和血管ADM含量,及竞争性定量RT-PCR方法测定心肌和血管ADM mRNA与RAMP2 mRNA含量。结果表明,NOS阻断剂L-NNA应用4周后动物血压明显升高、心肌肥厚。心重（mg）/体重（g）比值增加35.5％（P<0.01）。血浆、心肌和血管的ADM-ir较对照组分别增加80％、72％和57％（均P<0.01）。高血压大鼠心肌和血管ADM mRNA含量显著增加,分别较正常大鼠高50％（P<0.05）和102.9％（P<0.05）。高血压大鼠心肌和血管的RAMP2　mRNA含量均显著增加,分别较正常大鼠高132％（P<0.01）和87％（P<0.01）。高血压大鼠心肌和血管ADM的升高与RAMP2的升高程度呈明显的正相关,其相关系数分别为0.741和0.885。上述观察结果表明,高血压时血浆、心肌和血管ADM水平升高,心肌和血管ADM与RAMP2基因表达上调,提示ADM/RAMP2系统在高血压发病中可能具有重要作用。     

蓝藻生物节律性分子调控机制的研究进展

生物钟现象是一种普遍存在于生物界细胞的内源节律性保持机制。生物钟机制的存在可以使生物体的代谢行为产生并维持以24 h为周期的昼夜节律,从而更好地适应于地球自转所产生的环境条件昼夜间节律性变化。蓝藻是目前生物钟分子机制研究中的模式生物,其依赖于k ai基因家族成员的核心生物钟调控模式已经被众多研究者详细阐明。蓝藻生物钟的核心振荡器是由蓝藻k aiA/B/C的编码产物来调控的,Kai蛋白的表达模式具有节律性。KaiC蛋白磷酸化状态的节律性循环及输入、输出途径相关组成蛋白的翻译后修饰状态节律性循环共同组成其反馈回路,负责维持生物钟节律性振荡的持续进行并与环境周期保持同步。传统的蓝藻生物钟分子机制模型认为,节律性表达基因翻译产物的转录/翻译负反馈抑制环是生物节律性维持和输出的关键。遗憾的是,在其它物种生物钟分子机制研究中未发现由kai基因家族成员同源基因组成的节律性标签,这表明以k aiA/B/C为核心振荡器的生物钟系统并不是一种跨物种保守的生物钟系统。近期,人们发现非转录/翻译依赖的振荡器(NTO)也具有成为生物节律性产生和维持的“源动力”的可能。过氧化物氧化还原酶(PRX)氧化还原状态节律性是第一种被报道的跨物种保守的NTO节律性标签,这也日渐成为蓝藻生物钟分子机制研究新的热点。     

Identifying Adult Dengue Patients at Low Risk for Clinically Significant Bleeding

Background

Clinically significant bleeding is important for subsequent optimal case management in dengue patients, but most studies have focused on dengue severity as an outcome. Our study objective was to identify differences in admission parameters between patients who developed clinically significant bleeding and those that did not. We sought to develop a model for discriminating between these patients.

Methods

We conducted a retrospective study of 4,383 adults aged >18 years who were hospitalized with dengue infection at Tan Tock Seng Hospital, Singapore from 2005 to 2008. Patients were divided into those with clinically significant bleeding (n = 188), and those without (n = 4,195). Demographic, clinical, and laboratory variables on admission were compared between groups to determine factors associated with clinically significant bleeding during hospitalization.

Results

On admission, female gender (p<0.001); temperature >38°C (p<0.001); nausea/vomiting (p = 0.009) and abdominal pain/tenderness (p = 0.005); lower systolic blood pressure (p<0.001); higher pulse rate (p<0.001); increased absolute neutrophil count (ANC; p<0.001); reduced absolute lymphocyte count (ALC; p<0.001), haematocrit percentage (p<0.001) and platelet count (p = 0.04), and increased prothrombin time (p = 0.003) were significantly associated with clinically significant bleeding on univariate analysis. Multivariate analysis showed that independent variables in the final model were female gender (aOR 2.85; 95% CI: 1.9–4.33); temperature >38°C (aOR 1.81; 95% CI: 1.27–2.61), nausea/vomiting (aOR 1.39; 95% CI: 0.94–2.12), ANC (aOR 1.3; 95% CI: 1.15–1.46), ALC (aOR 0.4; 95% CI: 0.25–0.64), hematocrit percentage (aOR 0.96; 95% CI: 0.92–1.002) and platelet count (aOR 0.993; 95% CI: 0.988–0.998). At the cutoff of -3.919, the model achieved an AUC of 0.758 (sensitivity:0.87, specificity: 0.38, PPV: 0.06, NPV: 0.98).

Conclusion

Clinical risk factors associated with clinically significant bleeding were identified. This model may be useful to complement clinical judgement in triaging adult dengue patients given the dynamic nature of acute dengue, particularly in pre-identifying those less likely to develop clinically significant bleeding.     

Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro

Loss of cardiomyocytes by apoptosis is proposed to cause heart failure. Angiotensin II (ANG II), an important neurohormonal factor during heart failure, can induce cardiomyocyte apoptosis. Inasmuch as hexarelin has been reported to have protective effects in this process, we examined whether hexarelin can prevent cardiomyocytes from ANG II-induced cell death. Cultured cardiomyocytes from neonatal rats were stimulated with ANG II. Apoptosis was evaluated using fluorescence microscopy, TdT-mediated dUTP nick-end labeling (TUNEL) method, flow cytometry, DNA laddering, and analysis of cell viability by (3,4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). It was found that incubation with 0.1 micromol/l ANG II for 48 h increased cardiomyocyte apoptosis. Administration of 0.1 micromol/l hexarelin significantly decreased this ANG II-induced apoptosis and DNA fragmentation and increased myocyte viability. To further investigate the underlying mechanisms, caspase-3 activity assay and mRNA expression of Bax, Bcl-2, and growth hormone secretagogue receptor (GHS-R; the supposed hexarelin binding site) were examined. GHS-R mRNA was abundantly expressed in cardiomyocytes and was upregulated after administration of hexarelin. These results suggest that hexarelin abates cardiomyocytes from ANG II-induced apoptosis possibly via inhibiting the increased caspase-3 activity and Bax expression induced by ANG II and by increasing the expression of Bcl-2, which is depressed by ANG II. Whether the upregulated expression of GHS-R induced by hexarelin is associated with this antiapoptotic effect deserves further investigation.     

Extracellular hydrolase enzyme production by soil fungi from King George Island, Antarctica

Various microbial groups are well known to produce a range of extracellular enzymes and other secondary metabolites. However, the occurrence and importance of investment in such activities have received relatively limited attention in studies of Antarctic soil microbiota. In order to examine extracellular enzyme production in this chronically low-temperature environment, fungi were isolated from ornithogenic, pristine and human-impacted soils collected from the Fildes Peninsula, King George Island, Antarctica during the austral summer in February 2007. Twenty-eight isolates of psychrophilic and psychrotolerant fungi were obtained and screened at a culture temperature of 4°C for activity of extracellular hydrolase enzymes (amylase, cellulase, protease), using R2A agar plates supplemented with (a) starch for amylase activity, (b) carboxymethyl cellulose and trypan blue for cellulase activity or (c) skim milk for protease activity. Sixteen isolates showed activity for amylase, 23 for cellulase and 21 for protease. One isolate showed significant activity across all three enzyme types, and a further 10 isolates showed significant activity for at least two of the enzymes. No clear associations were apparent between the fungal taxa isolated and the type of source soil, or in the balance of production of different extracellular enzymes between the different soil habitats sampled. Investment in extracellular enzyme production is clearly an important element of the survival strategy of these fungi in maritime Antarctic soils.     

Efficacy of Oral Cryotherapy on Oral Mucositis Prevention in Patients with Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Randomized Controlled Trials

Objectives

Controversy exists regarding whether oral cryotherapy can prevent oral mucositis (OM) in patients with hematological malignancies undergoing hematopoietic stem cell transplantation (HSCT). The aim of the present meta-analysis was to evaluate the efficacy of oral cryotherapy for OM prevention in patients with hematological malignancies undergoing HSCT.

Methods

PubMed and the Cochrane Library were searched through October 2014. Randomized controlled trials (RCTs) comparing the effect of oral cryotherapy with no treatment or with other interventions for OM in patients undergoing HSCT were included. The primary outcomes were the incidence, severity, and duration of OM. The secondary outcomes included length of analgesic use, total parenteral nutrition (TPN) use, and length of hospital stay.

Results

Seven RCTs involving eight articles analyzing 458 patients were included. Oral cryotherapy significantly decreased the incidence of severe OM (RR = 0.52, 95% CI = 0.27 to 0.99) and OM severity (SMD = -2.07, 95% CI = -3.90 to -0.25). In addition, the duration of TPN use and the length of hospitalization were markedly reduced (SMD = -0.56, 95% CI = -0.92 to -0.19; SMD = -0.44, 95% CI = -0.76 to -0.13; respectively). However, the pooled results were uncertain for the duration of OM and analgesic use (SMD = -0.13, 95% CI = -0.41 to 0.15; SMD = -1.15, 95% CI = -2.57 to 0.27; respectively).

Conclusions

Oral cryotherapy is a readily applicable and cost-effective prophylaxis for OM in patients undergoing HSCT.     

Distribution characteristics and factors influencing the ecosystem in western Hubei

Western Hubei is the most concentrated area of forest resources in Hubei Province, and the knowledge of the distribution characteristics of ecosystem carbon density is important to understand the regional characteristics of carbon density and its mechanism of formation. Carbon density and factors influencing different layers in the ecosystem were studied by using field data. The average carbon density of ecosystems in western Hubei was 159.05 t/hm²; the carbon density of different forest types in descending order was Abies fargesii forests (362.25 t/hm²), mixed broadleaf-conifer forests (154.13 t/hm²), broad-leaved forests (146.09 t/hm²), and coniferous forests (135.76 t/hm²), and ecosystem carbon density increased with increasing age. The carbon density of the arborous layer, shrub layer, and soil layer of A. fargesii forests was significant higher than that of the other forests (P < 0.05), indicating the carbon storage per unit area of A. fargesii forests, which grow at higher elevations, was the greatest. The carbon density in arborous layers of broad-leaved forests, mixed broadleaf-conifer forests, and coniferous forests was 39.29 t/hm², 48.99 t/hm², and 48.39 t/hm², respectively. Those of the soil layer were 102.96 t/hm², 100.97 t/hm², and 82.37 t/hm², respectively, and there were no significant differences among them. Among the three forest types, carbon density in the litter layer was greater than that of the shrub layer, which indicated the litter layer plays an important role in carbon storage. The carbon density of mixed broadleaf-conifer forests was greatest, excluding A. fargesii forests, in medium (58.71 t/hm²) and mature forests (79.66 t/hm²). Thus, the carbon sink of mixed broadleaf-conifer forests had more potential than the others at the medium and mature forest stage. The soil layer carbon density in different forests constituted 60.67—70.48% of the entire ecosystem, and was 1.70—2.62 times greater than that of the arborous layer. There are many factors influencing ecosystem carbon density, which result from the interaction of environmental and topographical factors. The main explanatory variables of carbon density of the region were altitude, precipitation, and canopy density. The vegetation and soil layer carbon density increased as altitude increased, and the rate of change for every vertical 100 m was 1.3 t/hm² and 1.9 t/hm², respectively (P < 0.05). Although the annual average precipitation only affected the carbon density of the vegetation, it increased to 4 t/hm² (P < 0.01) when average precipitation was >100 mm.     

Alterations to the protein profile of bladder carcinoma cell lines induced by plant extract MINA‐05 in vitro

Bladder cancer (BLCa) is a severe urological cancer of both men and women that commonly recurs and once invasive, is difficult to treat. MINA‐05 (CK Life Sciences Int'l, Hong Kong) is a derivative of complex botanical extracts, shown to reduce cellular proliferation of bladder and prostate carcinomas. We tested the effects of MINA‐05 against human BLCa cell sublines, B8, B8‐RSP‐GCK, B8‐RSP‐LN and C3, from a transitional cell carcinoma, grade IV, to determine the molecular targets of treatment by observing the cellular protein profile. Cells were acclimatised for 48 h then treated for 72 h with concentrations of MINA‐05 reflecting IC₅₀, IC₅₀ and 2×IC₅₀ (n = 3) or with vehicle, (0.5% DMSO). Dose‐dependant changes in protein abundance were detected and characterised using 2‐dimensional electrophoresis and MS. We identified 10 proteins that underwent changes in abundance, pI and/or molecular mass in response to treatment. MINA‐05 was shown to influence proteins across numerous functional classes including cytoskeletal proteins, energy metabolism proteins, protein degradation proteins and tumour suppressors, suggesting a global impact on these cell lines. This study implies that the ability of MINA‐05 to retard cellular proliferation is attributed to its ability to alter cell cycling, metabolism, protein degradation and the cancer cell environment.